Feed Articles

ANALYSIS OF COCA-COLA SHARES

1Q results

The company's 1Q 2023revenue grew 5% year-over-year to nearly $11 billion, with organic revenue growing 12%. Global unit volume grew 3% y/y and concentrate sales were down two percentage points, mainly due to the timing of concentrate shipments and fewer days in the quarter. Analysts had expected a 0.62% year-on-year decline in concentrate sales.

Comparable operating margin increased to 31.8% from 31.4% in 1Q last year. Free cash flow decreased by approximately EUR 520 million in 1Q. This represents a negative USD 120 million in cash flow. USD

Outlook for 2023

Coca-Cola confirmed all points of its annual outlook. Adjusted organic sales are expected to grow by 7-8% on the company's estimates against market expectations of 7.84%. On a comparable earnings per share basis, the company expects growth of between 4-5%, which includes the negative impact of foreign exchange expected to be 3-4%.

Capital expenditures are expected to reach USD 1.9 billion, according to the information provided

2Q outlook

The company expects comparable sales to be negatively impacted by currency movements of 3-4%. Comparable earnings per share are then expected to be negatively impacted by 2-3%.

Coca-Cola share development

A community member's personal view, not investment advice. Community Guidelines

Follow Bulios on Google News

Be among the first to discover new analyses, news and market moves.

Follow

Recommended articles

Read more

Expensive oil was supposed to sink them; these 3 cruise lines instead report records and expect further growth

Oil this year soared to $138 per barrel, and cruise ships, which burn hundreds of thousands of tons of it annually, were supposed to be the first to suffer. Instead, all three largest cruise operators raised their profit outlooks, yet for a dollar of profit the market pays almost twice as much for…

MC
Milan Charvat
· 5h
Read more
BLACK

Man with Parkinson's stood up and walked away after an injection. The drugmaker's stock still fell 20%

A man with Parkinson's who couldn't get up from a chair walked out through the door on his own after a year of treatment with his own cells. The company behind the treatment raised $140.6 million in its IPO, and three weeks later its stock is 20% cheaper, even though there hasn't been a single…

MC
Milan Charvat
· 10h
Read more
BLACK

Dividends Above 10%? No Problem for These Stocks

A yield of over 15% a year sounds almost unbelievable in the stock market, yet several established US-listed securities are offering just that today. Mortgage REITs and leveraged bond funds earn money from the difference between the yield on mortgages or bonds and the cost of short-term financing,…

KJ
Kryštof Jáně
· 13h

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy